- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Ino
Recent news which mentions Ino
Why You Should Buy Moderna Stock at Every Dip
December 10, 2021
From InvestorPlace
Here's Why These 3 COVID-19 Vaccine Stocks Got Crushed This Week
December 03, 2021
From Motley Fool
2 Stocks That Are Down 60% (or More) From Their 52-Week Highs
December 03, 2021
From Motley Fool
20 Stocks Moving in Monday's Pre-Market Session
November 29, 2021
From Benzinga
Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant
November 29, 2021
From Benzinga
Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen
November 21, 2021
From Motley Fool
3 Vaccine Latecomers That Could Double Your Money
November 21, 2021
From Motley Fool
Does This News Make Inovio Pharmaceuticals Stock a Buy?
November 17, 2021
Tickers
INO
From Motley Fool
Inovio Pharmaceuticals (INO) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
INO
From Motley Fool
RBLX Stock Alert: What Is Going on With Roblox Shares Today?
November 09, 2021
From InvestorPlace
INO Stock: The Covid-19 Vaccine News Helping Inovio Power Higher
November 09, 2021
From InvestorPlace
FDA Lifts Clinical Hold On Inovio's COVID-19 Vaccine Trial
November 09, 2021
Tickers
INO
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
From Benzinga
4 Growth Stocks With 187% to 434% Upside, According to Wall Street
October 13, 2021
From Motley Fool
Is This The Turning Point for Inovio?
October 06, 2021
From Motley Fool
Is Vaccine Latecomer Inovio Making a Comeback?
September 29, 2021
From Motley Fool
5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch
September 18, 2021
From Motley Fool
Looking Into Inovio Pharmaceuticals's Return On Capital Employed
September 16, 2021
Tickers
INO
From Benzinga
5 Stocks With 195% to 467% Upside, According to Wall Street
September 08, 2021
From Motley Fool
Novavax Stock Is a Steal Here If You Believe It Will Come Through
September 03, 2021
From InvestorPlace
Etsy And NetApp Lead The S&P 500
August 26, 2021
From Benzinga
Inovio Pharmaceuticals Stock Nears End Of Technical Pattern
August 26, 2021
Tickers
INO
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.